SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
350.00    12.00 (3.55%)
Bid:
350.00
Ask:
352.00
Spread: 2.00 (0.571%)
Market Cap: £3.46b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Convertible Loan Notes

23 May 2012 07:00

RNS Number : 8980D
Vane Minerals PLC
23 May 2012
 



VANE Minerals plc (AIM:VML)

("VANE" or the "Company")

Convertible Loan Notes

VANE is pleased to announce that the Company has reached an agreement with the holders of its convertible loan notes.

VANE currently has two convertible loan notes outstanding, the first for £1m, issued to Geiger Counter Limited in May 2007 which was due to be repaid at end of May 2012; and the second loan, amounting to £500,000, was issued to City Natural Resources High Yield Trust plc in September 2007 and was due to be repaid at end of September 2012. Both funds are managed by New City Investment Managers.

The principal points of the agreement are:

·; VANE will repay £500,000 on 31 May 2012 out of existing cash resources to settle the loan with City Natural Resources High Yield Trust plc

·; VANE will carry forward a loan note of £1 million, issued to Geiger Counter Limited (the "new loan note")

·; The maturity date for the new loan note is 31 May 2017

·; The new loan note will continue to attract interest at 8% per annum, payable every six months

·; The new loan note is convertible by the holder, at any time, into 80 million ordinary shares in VANE at a price of 1.25p (a 34 per cent premium to the current mid-market price of 0.935p per ordinary share as at the close of business on 22 May 2012)

·; The Company may repay the loan note early in the event that i) the share price is equal or greater than 2.5p or ii) after three years, the share price is equal or greater than 1.25p. The amount which the Company would have to pay in these circumstances is calculated by multiplying the prevailing share price by the number of shares into which the loan note is convertible at 1.25p per Ordinary Share

·; VANE has undertaken to seek shareholder approval to dis-apply the relevant pre-emption rights at a general meeting, thus enabling conversion of the new loan note

David Newton, Chief Executive of VANE, commented:

"I am delighted to have reached this agreement with the loan note holders. The maximum dilution to existing shareholders would equate to only 15.3% of the enlarged share capital of the Company and the agreement allows the Company to continue to devote its current cash resources to the development of its highly promising copper and uranium exploration assets."

 

For further information, please contact:

VANE Minerals Plc

+44 (0) 20 7667 6322

David Newton

CEO VANE Minerals plc

 

 

Allenby Capital (Nominated Adviser & Joint Broker)

Jeremy Porter/Alex Price

 

Northland Capital Markets (Joint Broker)

Louis Castro

 

 

+44 (0) 203328 5656

 

 

+44 (0) 20 7796 8821

 

Bankside Consultants

 

+44 (0) 20 7367 8888

Simon Rothschild

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAASAAFNAEAF
Date   Source Headline
2nd Jun 20269:59 amRNSHolding(s) in Company
28th May 20263:34 pmRNSCompletion of ASP MWI Holdings, Inc. Acquisition
18th May 20264:59 pmRNSDirector/PDMR Shareholding
12th May 20264:43 pmRNSCompletion of ASP CPM Holdings, Inc. Acquisition
7th May 202612:02 pmRNSAGM 2026 Results
7th May 20267:00 amRNSAGM Trading Update
5th May 20263:42 pmRNSNotification of Major Holdings
1st May 20268:00 amRNSReadmission - Rosebank Industries plc
1st May 20267:00 amRNSAdmission to trading on the Main Market
28th Apr 20266:00 pmRNSRosebank Industries
27th Apr 202611:27 amRNSPublication of Prospectus
15th Apr 20263:34 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSUpdate on Intention to Move to Main Market
1st Apr 202611:04 amRNSHolding(s) in Company
31st Mar 20269:24 amRNSNotification of Major Holdings
31st Mar 20269:23 amRNSNotification of Major Holdings
31st Mar 20267:00 amRNSIntention to move from AIM to the Main Market
27th Mar 20269:00 amRNSNotifications of Major Holdings
27th Mar 20269:00 amRNSNotification of Major Holdings
25th Mar 202612:49 pmRNSNotification of Major Holdings
25th Mar 20268:16 amRNSAdmission of New Ordinary Shares
23rd Mar 202612:17 pmRNSResult of General Meeting
13th Mar 20269:19 amRNSNotification of Major Holdings
13th Mar 20269:19 amRNSNotification of Major Holdings
13th Mar 20269:18 amRNSNotification of Major Holdings
11th Mar 202610:51 amRNSNotification of Major Holdings
11th Mar 202610:51 amRNSNotification of Major Holdings
10th Mar 20263:44 pmRNSNotifications of Major Holdings
6th Mar 20267:30 amRNSRestoration - Rosebank Industries Plc
6th Mar 20267:00 amRNSPublication of Admission Document
4th Mar 20262:05 pmRNSResults of Retail Offer
4th Mar 20267:00 amRNSAppointment of Chief Operating Officer
3rd Mar 20264:51 pmRNSResults of the Institutional Capital Raise
3rd Mar 20269:46 amRNSRetail Offer by RetailBook
3rd Mar 20269:45 amRNSMW Components & CPM Acquisition and Capital Raise
3rd Mar 20269:01 amRNSAudited Results for year ended 31 December 2025
23rd Feb 20261:31 pmRNSNotification of Major Holdings
17th Feb 20263:38 pmRNSNotification of Major Holdings
16th Feb 202612:52 pmRNSHolding(s) in Company
16th Feb 202610:03 amRNSSuspension - Rosebank Industries plc
16th Feb 20269:41 amRNSPotential Transaction
3rd Feb 20263:30 pmRNSNotifications of Major Holdings
20th Jan 20261:00 pmRNSProposed Appointment of Chief Operating Officer
24th Nov 20257:00 amRNSTrading Update
14th Nov 20257:00 amRNSAppointment of Non-Executive Director
12th Nov 20259:38 amRNSHolding(s) in Company
18th Sep 20259:25 amRNSHolding(s) in Company
16th Sep 20259:00 amRNSHolding(s) in Company
26th Aug 202510:14 amRNSHolding(s) in Company
21st Aug 20258:00 amRNSReadmission - Rosebank Industries plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.